What departments does Iovance Biotherapeutics, Inc. have?

Iovance Biotherapeutics, Inc. has employees across 12 departments including Finance, Entrepreneurship, Quality Assurance, Healthcare Services, Human Resources.

What is the largest department at Iovance Biotherapeutics, Inc.?

The largest department at Iovance Biotherapeutics, Inc. is Engineering with 6 employees.

Where are Iovance Biotherapeutics, Inc. employees located globally?

Iovance Biotherapeutics, Inc. has employees across 4 continents and 9 countries including Iran, India, Netherlands, France, United Kingdom Of Great Britain And Northern Ireland.

How has Iovance Biotherapeutics, Inc.'s team size changed over time?

Iovance Biotherapeutics, Inc.'s team has grown from approximately 649 to 870 employees based on available data.

Iovance Biotherapeutics, Inc. Employee Directory

Q: Who are Iovance Biotherapeutics, Inc.'s key employees and leadership?

Iovance Biotherapeutics, Inc.'s key employees include: Executive Assistant To Chief Medical Officer: C. A., Chief Financial Officer: B. B., Vp Of Finance, Corporate Controller: J. H., Vice President Of Finance, Corporate Controller: C. S..

Biotechnology ResearchCalifornia, United States501-1000 Employees

Iovance Biotherapeutics, Inc. is a biotechnology company focused on developing tumor infiltrating lymphocyte (TIL) therapies for cancer patients. It aims to harness the immune system to recognize and destroy cancer cells in each individual, pursuing a per-patient treatment strategy. The TIL platform has produced clinical data suggesting activity across several solid tumor types, and the company continues to advance cell-therapy innovations, including gene-edited approaches. The firm is headquartered in the San Francisco Bay Area and operates the Iovance Cell Therapy Center manufacturing facility in Philadelphia, with a research site in Tampa, Florida. As it expands its commercial launch and research efforts, it is building internal manufacturing capabilities to support scale and execution. In 2025, the company appointed Corleen Roche as Chief Financial Officer, with the appointment effective in August 2025.

Iovance Biotherapeutics, Inc. Global Highlights

North America
990

United States Of America
987
Canada
3

Europe
16

United Kingdom Of Great Britain And Northern Ireland
9
Netherlands
4
Switzerland
2
France
1

Asia
3

India
2
Iran
1

Oceania
1

Australia
1

Iovance Biotherapeutics, Inc.'s Leadership

B. B.
Chief Financial Officer
Mobile Phone
Email
J. H.
Vp Of Finance, Corporate Controller
Mobile Phone
Email
C. S.
Vice President Of Finance, Corporate Controller
Mobile Phone
Email
C. A.
Executive Assistant To Chief Medical Officer
Mobile Phone
Email
N. H.
Owner
Mobile Phone
Email
K. S.
Executive Vice President, Quality
Mobile Phone
Email
M. B.
Global Executive Medical Director (ex-Us) Til Therapy (immuno-Oncology)
Mobile Phone
Email
E. G.
Human Resources Director
Mobile Phone
Email

Iovance Biotherapeutics, Inc. Employee Metrics

100%

50%

0%

2026

2025

Manufacturing
Operations
Quality Assurance
Engineering
Analytics
Other
Legal
Administrative
Biotechnology
Supply Chain

Contact profiles from Iovance Biotherapeutics, Inc.

Name

Title

Contact Info

Location

Last Update

C. A.
Executive Assistant To Chief Medical Officer
Mobile Phone
Email
Bay
Apr 16, 2026
B. B.
Chief Financial Officer
Mobile Phone
Email
Aug 10, 2023
N. H.
Owner
Mobile Phone
Email
Oct 21, 2024
K. S.
Executive Vice President, Quality
Mobile Phone
Email
Bay
Jul 22, 2026
J. H.
Vp Of Finance, Corporate Controller
Mobile Phone
Email
Bay
Jun 29, 2026
C. S.
Vice President Of Finance, Corporate Controller
Mobile Phone
Email
Oct 22, 2024
M. B.
Global Executive Medical Director (ex-Us) Til Therapy (immuno-Oncology)
Mobile Phone
Email
Netherlands
Jul 06, 2026
E. G.
Human Resources Director
Mobile Phone
Email
Jun 26, 2026
J. W.
Associate Director, Hr Operations
Mobile Phone
Email
Bay
Jun 29, 2026
A. R.
Director, Congress Strategy
Mobile Phone
Email
Jun 27, 2026

Frequently Asked Questions

What is Iovance Biotherapeutics, Inc. known for?

Iovance Biotherapeutics, Inc. was founded in 2007 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at

+1-650-260-****

. Explore Iovance Biotherapeutics, Inc.'s company overview page for more information.

What is Iovance Biotherapeutics, Inc.'s most common email format?

Iovance Biotherapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Iovance Biotherapeutics, Inc. email formats with LeadIQ.

How many employees does Iovance Biotherapeutics, Inc. have currently?

Iovance Biotherapeutics, Inc. has approximately 921 employees as of July 2026. These team members are located across 4 continents, including North AmericaEuropeAsia.

Who are Iovance Biotherapeutics, Inc.'s key employees and leadership?

As of July 2026, Iovance Biotherapeutics, Inc.'s key employees include:

Chief Financial Officer: B. B.
Vp Of Finance, Corporate Controller: J. H.
Vice President Of Finance, Corporate Controller: C. S.
Executive Assistant To Chief Medical Officer: C. A.
Owner: N. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Iovance Biotherapeutics, Inc. Employee Directory

Find Iovance Biotherapeutics, Inc. employees' phone numbers or email addresses

Name search is limited — try advanced search instead